Glycinebetaine

Glycinebetaine

SCHEMBL3423115

CCCCCCCCCCCCCCCCCCOC(=O)C(C)(C)N.C[N+](C)(C)CC(=O)[O-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
NAAA Q02083 1/20 0.40
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
EPHX1 P07099 1/20 0.38
TSHR P16473 3/20 0.38
LMNA P02545 3/20 0.38
HTR2C P28335 1/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL13736533 1.00 RAD52 (0.53) RAD52NPSR1NAAAALDH1A1NPC1
Glycinebetaine SCHEMBL1245821 1.00 RAD52 (0.53) RAD52NPSR1NAAAALDH1A1NPC1
Glycinebetaine SCHEMBL23528235 1.00 RAD52 (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL5269129 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL593838 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL6667795 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL936782 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL4674831 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL22550911 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1
SCHEMBL3674103 0.84 NAAA (0.53) RAD52NPSR1NAAAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 CN claimed
WO-2024143154-A1 ANTIMICROBIAL PEPTIDE AND METHOD FOR PRODUCING SAME 住友化学株式会社 2024-07-04 WO disclosed
US-20240101751-A1 HOLLOW MICROBALLOON TOKUYAMA CORPORATION (JP) 2024-03-28 US disclosed
EP-4286439-A1 HOLLOW MICROBALLOON Tokuyama Corporation (JP) 2023-12-06 EP disclosed
US-20230270655-A1 PERSONAL CARE COMPOSITION AND USAGE METHOD THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-31 US disclosed
EP-4215246-A1 PERSONAL CARE COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-07-26 EP disclosed
US-20230203234-A1 HOLLOW MICROBALLOONS TOKUYAMA CORPORATION (JP) 2023-06-29 US disclosed
US-20230151179-A1 HOLLOW MICROBALLOONS FOR CMP POLISHING PAD TOKUYAMA CORPORATION (JP) 2023-05-18 US disclosed
EP-4039243-A1 COMPOSITION FOR AEROSOL COSMETICS, AND AEROSOL COSMETICS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-08-10 EP disclosed
EP-3842178-A1 BRAZING MATERIAL, BRAZING MEMBER, HEAT EXCHANGER, AND MANUFACTURING METHOD OF BRAZING MEMBER Harima Chemicals, Incorporated (JP) 2021-06-30 EP disclosed
EP-2642975-B1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO KK (JP) 2016-08-24 EP disclosed
US-9180079-B2 Skin external preparation and method of producing same SHOWA DENKO K.K. (JP) 2015-11-10 US disclosed
US-9012117-B2 Toner, developer, toner container, process cartridge, image forming method, and image forming apparatus RICOH COMPANY, LTD. (JP) 2015-04-21 US disclosed
US-8741520-B2 Image forming toner, image forming apparatus, image forming method, and process cartridge RICOH COMPANY, LTD. (JP) 2014-06-03 US disclosed
US-20130287718-A1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO K.K. (JP) 2013-10-31 US disclosed
EP-2642975-A2 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME Showa Denko K.K. (JP) 2013-10-02 EP disclosed
WO-2012153825-A2 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME SHOWA DENKO K.K. (JP) 2012-11-15 WO disclosed
US-20100316944-A1 TONER, DEVELOPER, TONER CONTAINER, PROCESS CARTRIDGE, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS RICOH COMPANY, LTD. (JP) 2010-12-16 US disclosed
WO-2010001770-A1 IMAGE FORMING TONER, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, AND PROCESS CARTRIDGE RICOH COMPANY, LTD. (JP) 2010-01-07 WO disclosed
EP-1857534-A1 DETERGENT COMPOSITION Ajinomoto Co., Inc. (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130287718-A1 SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME RBP4, RBP1, PROC RAD52 1096/4885NPSR1 3093/4885NAAA 2191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.